Director, Quality Assurance & Regulatory Affairs
Elisabeth Scheidl joined TRIO in January 2020 with 20 years of clinical research experience and an MSc in Biology/Zoology from the University of Vienna, Austria.
Before joining TRIO, Elisabeth worked in both small and large companies; biotech and pharmaceutical companies, as well as CROs. Her experience spans the range of Phase 1 to 3 clinical trials in allergy, endocrinology, vaccines, amongst other indications.
Elisabeth brings a strong understanding of quality management systems, auditing, compliance, strategic management, and the ability to think in a process-oriented and interdisciplinary manner to optimize and streamline process and procedures. Her working attitude is always proactive for the sake of prompt and targeted changes and adaptations of strategies and systems.